A detailed history of Pnc Financial Services Group, Inc. transactions in Standard Biotools Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 128 shares of LAB stock, worth $234. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128
Previous 128 -0.0%
Holding current value
$234
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$1.87 - $2.78 $16 - $25
-9 Reduced 6.57%
128 $0
Q4 2023

Feb 09, 2024

BUY
$1.59 - $2.73 $217 - $374
137 New
137 $0
Q1 2021

May 07, 2021

SELL
$3.94 - $7.09 $3,940 - $7,090
-1,000 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$4.34 - $11.43 $4,340 - $11,430
1,000 New
1,000 $7,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.